0001681871-17-000010.txt : 20170303 0001681871-17-000010.hdr.sgml : 20170303 20170303182731 ACCESSION NUMBER: 0001681871-17-000010 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170106 FILED AS OF DATE: 20170303 DATE AS OF CHANGE: 20170303 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Eldessouky Sam CENTRAL INDEX KEY: 0001558676 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 17665867 MAIL ADDRESS: STREET 1: 9 ROSZEL ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2017-01-06 0 0000885590 Valeant Pharmaceuticals International, Inc. VRX 0001558676 Eldessouky Sam 400 SOMERSET CORPORATE BOULEVARD BRIDGEWATER NJ 08807 0 1 0 0 SVP, CHIEF ACCOUNTING OFFICER Common Stock, no par value 2017-01-06 4 A 0 12799 0 A 66590 D Restricted Share Units 2017-01-06 4 A 0 8534 0 A 2020-01-06 Common Stock 8534 8534 D Non-Qualified Stock Options (right to purchase) 14.38 2017-03-01 4 A 0 31430 0 A 2027-03-01 Common Shares, no par value 31430 31430 D Represents the award of restricted share units (RSUs) which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Valeant Pharmaceuticals International, Inc. ("Valeant"). Represents a grant of performance-based RSUs. The target number of performance-based RSUs granted to the reporting person was 4,267 and the maximum number that can be distributed is 8,534. The performance-based RSUs shall vest and be distributed between 0-200% of target based on Valeant's total shareholder return (TSR) as measured on January 6, 2020 (the Measurement Date). If Valeant's TSR for the period between the grant date and the Measurement Date is below the 50th percentile ranking of the TSR for the applicable peer group, the reporting person will receive no more than the number of Common Shares equal to the target number of performance-based RSUs subject to the award. The options vest in equal installments on each of the first three anniversaries of the date of grant. Kelly Webber POA for Osama A. Eldessouky 2017-03-03